Synaptive Medical

Today, we honour our veterans and the families who stand beside them. Synaptive Medical is proud to partner with veterans’ hospitals, advancing the care that makes a difference and helping improve lives for the moments that matter most. To all who have served, and to those who support them: thank you for your courage, your sacrifice, and the freedom you’ve helped provide us all.

IN CASE YOU MISSED IT: Last month at the 2025 Congress of Neurological Surgeons (CNS) Patrick Pema (Hackensack Meridian School of Medicine / Hackensack Meridian Health) presented, "Volumetric Evaluation of Synaptive Magnetic Resonance Imaging for Stereotactic Radiosurgical Planning." Here's the summarized presentation, be sure to check it out.   Summary: In this study, Pema used contrast-enhanced imaging on the Synaptive 0.5T MR system to define treatment volumes for brain tumors compared to their existing 1.5T clinical MR system, and found no statistically significant difference between the treatment volumes defined at 0.5T compared to 1.5T. Pema concluded that the use of the Synaptive MRI for SRS planning produces clinically acceptable and accurate target delineation.   Learn more about Synaptive's Evry MRI — a next-generation, low-field 0.5T MRI with best-in-class head imaging: https://lnkd.in/g8P34Z7x   Acknowledgements:   Shabbar Danish, MD Timothy Chen, MD Michael Chaga Wenzheng Feng Tingyu Wang Jing Feng Darra Conti Ma Rhudelyn Rodrigo Nikitas Sgantzos Elizabeth Luick Daniel Thompson Joy Baldwin Brielle Latif Akil Anthony Joseph Hanley

Today at the 2025 Congress of Neurological Surgeons (CNS), Patrick Pema (Hackensack Meridian School of Medicine / Hackensack Meridian Health) presented his research, "Volumetric Evaluation of Synaptive Magnetic Resonance Imaging for Stereotactic Radiosurgical Planning." In this study, Pema used contrast-enhanced imaging on the Synaptive 0.5T MR system to define treatment volumes for brain tumors compared to their existing 1.5T clinical MR system, and found no statistically significant difference between the treatment volumes defined at 0.5T compared to 1.5T. Pema concluded that the use of the Synaptive MRI for SRS planning produces clinically acceptable and accurate target delineation. Learn more about Synaptive's Evry MRI — a next-generation, low-field 0.5T MRI with best-in-class head imaging: https://lnkd.in/g8P34Z7x #MRI #neurotechnology #2025CNS

COMPANY NEWS: Synaptive Medical and Centile Bioscience Partner to Advance AI-Enhanced Surgical Planning We are excited to share that today we announced a strategic partnership with Centile Bio, an emerging innovator in AI-powered brain analytics. The collaboration aims to integrate Centile Bio’s advanced neuroimaging intelligence into Synaptive’s Modus Plan™ software, combining best-in-class whole-brain tractography with quantitative brain modeling to enhance surgical planning. The integration is currently under development and intended for research and evaluation purposes only; future clinical use will be subject to applicable regulatory clearances and approvals. Since its launch in 2019, Modus Plan™ has advanced surgical planning by introducing automated whole-brain tractography that accurately maps and segments neural pathways into patient-specific bundles. The planned integration of Centile Bio’s AI technology into Modus Plan™ is expected to streamline manual workflows, increase anatomical precision, and improve diagnostic accuracy, helping clinicians plan procedures more efficiently and with greater confidence. Press release link: https://lnkd.in/gzrhRJ8f Cameron Piron | Jakob Seidlitz #neurotech #MRI #2025CNS

#2025CNS Poster: Synaptive Medical is excited to share that a poster will be presented at the 2025 Congress of Neurological Surgeons (CNS) 75th Annual Meeting, on a recent study by authors, Kimberly Agosto; Daniel Cummins, MD; S Javin Bose; Ziad Rifi, MD; Daniel R. Lefton, MD; J Mocco, MD, MS; and Christopher Kellner, MD (Icahn School of Medicine at Mount Sinai), "Free Water-Corrected Corticospinal Tractography Improves Prediction of Functional Outcome After Minimally Invasive Intracerebral Hemorrhage (ICH) Evacuation."    In this study, the Mount Sinai team found that the surgical plan tractography software, with free-water correction, demonstrated correlations with patient outcomes following minimally invasive ICH evacuation.    These findings highlight the potential of advanced tractography to enhance prognostic insight and support postoperative care.    If you're at #2025CNS this year, be sure to check out the poster and meet the Synaptive team on-site. (October 13-15, 2025, LA Convention Center, Exhibit Hall, Booth #266)   Learn more about Synaptive's tractography software: https://lnkd.in/gdhQdSzT

TODAY - Monday, October 13 - Wednesday, October 15, meet the Synaptive Medical team at the 2025 Congress of Neurological Surgeons (CNS) 75th Annual Meeting (Exhibit Hall Booth #266). 2025 CNS Annual Meeting Los Angeles Convention Center Exhibit Hall Booth #266 Learn more about Synaptive's next-gen precision imaging, navigation, & robotics: https://lnkd.in/g4FPX6hH See you in LA! #2025CNS

TODAY October 11th at #2025CNS: Synaptive Medical is proud to support Stryker's MIPS (Minimally Invasive Parafascicular Surgery) for Tumor and ICH Half-Day Course, showcasing the power of Synaptive’s tractography in advancing minimally invasive neurosurgery. Course Information: Congress of Neurological Surgeons (CNS) 75th Annual Meeting 2025 Course App link: https://lnkd.in/gJBa5Xvn Location: Los Angeles Convention Center, Room 304 ABC 12:45 - 4:15 p.m. (Pacific) #Tractography #ModusPlan #MIPS

It's been a great Day 1 at the Congress of Neurological Surgeons (CNS) 75th Annual Meeting 2025, Joint Tumor Section Symposium. Be sure to visit us (Concourse Hall, 152 & 153, Booth 202) to meet our team and learn about how Synaptive's surgical suite of products is advancing patient care in hospitals around the world. See you in LA! #2025CNS

Join the Synaptive Medical team in Los Angeles for the Congress of Neurological Surgeons (CNS) 75th Annual Meeting 2025, Joint Tumor Section Symposium, October 10-11, 2025, at the LA Convention Center in Los Angeles, CA. We will be in Concourse Hall, 152 & 153, Booth 202. This year’s theme, Beyond the Blade: Redefining the Role of the Tumor Neurosurgeon, highlights how neurosurgeons are pushing beyond traditional surgical boundaries to innovate, advocate, and advance patient care. See you in LA! #2025CNS

COMPANY NEWS: First Synaptive Medical system installed in Paris, France! 🇫🇷 Since our founding, Synaptive’s mission has been to help clinicians see with greater precision and clarity, improving patient care everywhere. We are proud to share that we have installed the first Synaptive Modus X robotic exoscope system in France, at the world-renowned Fondation Adolphe de Rothschild Hospital in Paris. Recently recognized by Newsweek as one of the World’s Best Specialized Hospitals 2026, the Fondation Adolphe de Rothschild Hospital is a global leader in neurology and neurosurgery. (Read their announcement on Linkedin: https://lnkd.in/eaVav5q9) This installation represents an important collaboration with Dr. Gilles Huberfeld, MD, PhD, neurologist and world-leading researcher, and marks an exciting step in bringing Synaptive's next-gen precision robotics to healthcare professionals across Europe — and beyond. 🔗 Learn more about Synaptive: www.synaptive.com #Neurosurgery #Innovation #MedTech #NeuroTech